NCT04039607 2026-02-19CheckMate 9DWBristol-Myers SquibbPhase 3 Active not recruiting732 enrolled 1 FDA
NCT01761266 2022-04-05A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Sorafenib in First-line Treatment of Participants With Unresectable Hepatocellular CarcinomaEisai Inc.Phase 3 Completed954 enrolled 19 charts 1 FDA